Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients

  • US 20130165484A1
  • Filed: 02/25/2013
  • Published: 06/27/2013
  • Est. Priority Date: 09/22/2005
  • Status: Active Grant
First Claim
Patent Images

1. A capsule comprising a pharmaceutical formulation of 5-methyl-1-phenyl-2-(1H)-pyridone, wherein said pharmaceutical formulation comprises, by weight, 5-30% of pharmaceutically acceptable excipients and 70-95% of 5-methyl-1-phenyl-2-(1H)-pyridone.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×